RUMOSPAS-10
MRP: 2,200
Packaging: 10x10
Pack Type: tablet
Composition:
Leflunomide 10mg
Indication:
Used for the treatment of rheumatoid arthritis and psoriatic arthritis to reduce inflammation, relieve symptoms, and slow disease progression.
Description:
Leflunomide 10 mg is a Disease-Modifying Anti-Rheumatic Drug (DMARD) used to treat rheumatoid arthritis and psoriatic arthritis. It works by inhibiting dihydroorotate dehydrogenase, an enzyme essential for DNA synthesis in activated T-cells, thus reducing autoimmune inflammation. The 10 mg dosage may be used for dose titration, maintenance therapy, or in patients who cannot tolerate higher doses.
Tags:
- Controls inflammation and autoimmune activity in arthritis
- Reduces joint swelling, stiffness, and pain
- Slows disease progression and joint damage
- Suitable for mild cases or those requiring dose adjustment
- Can be used in combination therapy
Usage Information
Dosage
Typical adult dose: 10 mg once daily or as directed by the physician May be used in step-down therapy or in combination with other DMARDs Swallow whole with or without food Monitoring of liver function and blood counts is recommended regularly
Side Effects
Common: Diarrhea, nausea, mild liver enzyme elevation Less common: Rash, dizziness, fatigue, mild respiratory symptoms Serious: Liver damage, bone marrow suppression, interstitial lung disease (rare)
Contraindications
Pregnancy – contraindicated due to high risk of fetal toxicity Severe liver disease History of serious infections or immune suppression Known allergy to Leflunomide or its metabolites Not recommended in breastfeeding women